Atlas Trials

Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder

Clinical trial NCT01716624 · COMPLETED

Trial details

NCT number
NCT01716624
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neurogenic Bladder
Start date
2011-05-01
Primary completion
2012-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.